MENU
PRLD
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.52
Change
+$0.05 (+3.40%)
Capitalization
83.2M
125 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prelude Therapeutics (PRLD) Earnings Date & Reports

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs... Show more

A.I. Advisor
published Earnings

PRLD is expected to report earnings to fall 33.65% to -17 cents per share on March 18

Prelude Therapeutics PRLD Stock Earnings Reports
Q4'25
Est.
$-0.17
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.10
The last earnings report on November 12 showed earnings per share of -25 cents, beating the estimate of -36 cents. With 548.54K shares outstanding, the current market capitalization sits at 83.20M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PRLD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRLD showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PRLD
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com